We are live on ! Find out more
ACET icon

Adicet Bio
ACET

56 hedge funds and large institutions have $169M invested in Adicet Bio in 2019 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 27 increasing their positions, 6 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

400% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 2

350% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 6

17% more funds holding

Funds holding: 48 → 56 (+8)

0.01% more ownership

Funds ownership: 0.46% → 0.47% (+0.01%)

10% less capital invested

Capital invested by funds: $189M → $169M (-$19.7M)

Holders
56
Holders Change
+8
Holders Change %
+16.67%
% of All Funds
1.23%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
10
Increased
27
Reduced
6
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
HighTower Advisors
HighTower Advisors
Illinois
+$1.5M
2
PSP
Principal Street Partners
Tennessee
+$1.5M
3
AG
Artal Group
Luxembourg
+$1.4M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$1M
5
Northern Trust
Northern Trust
Illinois
+$654K

Top Sellers

Rank Fund Capital Flow
1
Jennison Associates
Jennison Associates
New York
-$1.83M
2
DAM
Deltec Asset Management
New York
-$789K
3
RL
Ruffer LLP
United Kingdom
-$674K
4
BFM
Boothbay Fund Management
New York
-$264K
5
Citigroup
Citigroup
New York
-$33.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
OAM
26
Oxford Asset Management
United Kingdom
$285K +$193K +173 +150%
California State Teachers Retirement System (CalSTRS)
27
California State Teachers Retirement System (CalSTRS)
California
$212K +$8.93K +8 +4%
State of Wisconsin Investment Board
28
State of Wisconsin Investment Board
Wisconsin
$199K +$119K +107 +114%
RhumbLine Advisers
29
RhumbLine Advisers
Massachusetts
$172K +$21.2K +19 +12%
EGM
30
Engineers Gate Manager
New York
$169K +$191K +171 New
Goldman Sachs
31
Goldman Sachs
New York
$160K +$43.5K +39 +32%
AllianceBernstein
32
AllianceBernstein
Tennessee
$156K +$70.3K +63 +66%
BAM
33
Brave Asset Management
New Jersey
$135K +$153K +137 New
ARTA
34
A.R.T. Advisors
New York
$133K +$150K +134 New
PPA
35
Parametric Portfolio Associates
Washington
$118K -$10K -9 -7%
ProShare Advisors
36
ProShare Advisors
Maryland
$102K +$3.35K +3 +3%
Manulife (Manufacturers Life Insurance)
37
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$96K – – –
Wells Fargo
38
Wells Fargo
California
$94K +$79.3K +71 +296%
AIG
39
American International Group
New York
$86K +$2.23K +2 +2%
Barclays
40
Barclays
United Kingdom
$76K -$12.3K -11 -13%
New York State Common Retirement Fund
41
New York State Common Retirement Fund
New York
$67K +$5.58K +5 +8%
UBS Group
42
UBS Group
Switzerland
$67K +$70.3K +63 +1,575%
Deutsche Bank
43
Deutsche Bank
Germany
$34K -$3.35K -3 -8%
Victory Capital Management
44
Victory Capital Management
Texas
$25K +$27.9K +25 New
Legal & General Group
45
Legal & General Group
United Kingdom
$22K – – –
Bank of Montreal
46
Bank of Montreal
Ontario, Canada
$22K +$11.2K +10 +83%
BNP Paribas Financial Markets
47
BNP Paribas Financial Markets
France
$15.1K +$6.7K +6 +67%
Citigroup
48
Citigroup
New York
$12K -$33.5K -30 -71%
Fifth Third Bancorp
49
Fifth Third Bancorp
Ohio
$9K +$10K +9 New
AIP
50
Ameritas Investment Partners
Nebraska
$5K – – –
1
2
3

ACET Hedge Fund Activity: Q3 2019 in Review

56 of the 4,561 institutional investors tracked by Wall St. Rank reported a position in Adicet Bio (ACET) for Q3 2019, worth a combined $169M — down 10% from $189M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new ACET positions and 2 closed out — a net gain of 8 holders — while 27 added to existing stakes and 6 trimmed.

The largest buyer was HighTower Advisors, opening a new position worth an estimated $1.5M. The largest seller was Jennison Associates, cutting an estimated $1.83M.

  • 56 institutional investors held Adicet Bio (ACET) as of Q3 2019, up from 48 in Q2 2019.
  • Funds reported $169M of Adicet Bio stock for Q3 2019, down 10% quarter-over-quarter.
  • 10 funds opened new Adicet Bio positions in Q3 2019 and 2 closed out, a net change of +8 holders.
  • The largest Adicet Bio buyer in Q3 2019 was HighTower Advisors, an estimated $1.5M added.
  • The largest Adicet Bio seller in Q3 2019 was Jennison Associates, an estimated $1.83M sold.

Based on aggregated 13F filings for Q3 2019.